Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
复制标题
寻求治疗性 A2A 拮抗剂的进展：腺苷 A2A 受体选择性拮抗剂 KW6002：针对帕金森病的新型非多巴胺能疗法的研究和开发。
DOI：
10.1212/01.wnl.0000095219.22086.31
复制
发表时间：
2003
期刊：
影响因子：
9.9
通讯作者：
Jen
中科院分区：
文献类型：
--
作者：
Kase,Hiroshi;Aoyama,S;Ichimura,M;Ikeda,K;Ishii,A;Kanda,T;Koga,K;Koike,N;Kurokawa,M;Kuwana,Y;Mori,A;Nakamura,J;Nonaka,H;Ochi,M;Saki,M;Shimada,J;Shindou,T;Shiozaki,S;Suzuki,F;Takeda,M;Yanagawa,K;Richardson,PJ;Jen
